Sympathetic Neurotransmitters and Ouabain Hypertension

交感神经递质和哇巴因高血压

• 批准号: 6968175
• 负责人: Withrow Gil Wier
• 金额: $ 34.76万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6968175
• 关键词: adenosine triphosphate; calcium flux; calcium indicator; clinical research; essential hypertension; genetically modified animals; laboratory mouse; laboratory rat; microelectrodes; muscle contraction; neuromuscular transmission; neuropharmacology; neuroregulation; neurotransmitter transport; norepinephrine; ouabain; protein isoforms; sodium ion; sodium potassium exchanging ATPase; sympathetic nervous system; synaptic vesicles; vascular smooth muscle; vascular smooth muscle nervous control

Ouabain-induced hypertension is characterized by hyperactivity of the sympathetic nervous system and increased contraction of vascular smooth muscle. It may also involve changes in sympathetic neuromuscular transmission in small arteries. The proposed research aims first to determine certain basic mechanisms of sympathetic transmitter release in small arteries, and then, to determine how these are affected by ouabain. Basic premises of the research are i) that sympathetic neuromuscular transmission and arterial contraction importantly involve the two co-transmitters, ATP and nor-epinephrine (NE) and, ii) that these two neurotransmitters are differentially released by Ca 2+ dependent mechanisms that are not yet completely known, possibly involving different synaptic vesicles, 'residual [Ca2+] ' and stored Ca 2+ (in addition to Ca 2+ entry). An overall hypothesis on mechanisms of ouabain actions is that inhibition of nerve terminal Na + pumps increases 'residual' [Ca 2+] and/or stored Ca 2+(thereby increasing NE and ATP release) and that the increases in terminal [Ca 2+] are mediated by Na/Ca exchange. Specific Aims are: 1) Determine the probabilities, at individual sympathetic nerve varicosities, of ATP and NE release, 2) Measure the sizes of ATP and NE transmitter packets ('quanta'), 3) Test the hypothesis that differential release of NE and ATP results from the release of different types of synaptic vesicles, 4) Test the hypothesis that acute, low-dose, ouabain inhibits the alpha3-isoform of the Na/K-ATPase in sympathetic varicosities and changes the probability of release, but not quantal size, 5) Determine whether release probability or quantal size is altered in ouabain hypertensive rats. Rat and mouse mesenteric small arteries will be loaded with fluorescent Ca 2+ indicators and studied in a myograph that permits simultaneous confocal fluorescence imaging, electrical stimulation/recording, and recording of isometric force development. Mice with genetically altered Na/Ca exchangers or ATP receptors will be used. Junctional Ca 2+ transients (jCaTs) will be used to measure neurally released ATP. Carbon fiber microelectrodes and amperometry will be used to measure NE release as 'NE oxidation currents' (NEOCs). The research will measure NE and ATP release together for the first time and thereby determine some of the basic mechanisms that control neurogenic contractions of arteries. will elucidate the mechanisms by which sympathetic nerves contribute to ouabain-induced hypertension.

哇巴因引起的高血压的特征在于交感神经系统的过度活跃和血管平滑肌的收缩增加。它也可能涉及小动脉中交感神经肌肉传递的变化。拟议的研究旨在首先确定小动脉中交感神经递质释放的某些基本机制，然后确定哇巴因如何影响这些机制。研究的基本前提是：i）交感神经肌肉传递和动脉收缩重要地涉及两种共递质，ATP和去甲肾上腺素（NE），ii）这两种神经递质通过尚不完全清楚的Ca 2+依赖机制差异释放，可能涉及不同的突触小泡，“残余[Ca 2 +]”和储存的Ca 2+（除了Ca 2+内流之外）。关于哇巴因作用机制的总体假设是，抑制神经末梢Na +泵增加“残余”[Ca 2+]和/或储存的Ca 2+（从而增加NE和ATP释放），并且末梢[Ca 2+]的增加是由Na/Ca交换介导的。具体目标是：1）测定单个交感神经曲张处ATP和NE释放的概率，2）测量ATP和NE递质包的大小（“量子”），3）检验NE和ATP的差异释放是由不同类型的突触囊泡的释放引起的假设，4）检验急性，低剂量，哇巴因抑制交感静脉曲张中Na/K-ATP酶的α 3亚型， 5）确定哇巴因高血压大鼠的释放概率或量子大小是否改变。大鼠和小鼠肠系膜小动脉将装载荧光Ca 2+指示剂，并在允许同时进行共聚焦荧光成像、电刺激/记录和等长力发展记录的肌电描记器中进行研究。将使用具有遗传改变的Na/Ca交换剂或ATP受体的小鼠。将使用连接Ca 2+瞬变（jCaTs）来测量神经释放的ATP。将使用碳纤维微电极和电流分析法测量NE释放作为“NE氧化电流”（NEOC）。这项研究将首次测量NE和ATP的释放，从而确定控制动脉神经性收缩的一些基本机制。 将阐明交感神经参与哇巴因引起的高血压的机制。